rs780668

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018344.6(SLC29A3):​c.473C>T​(p.Ser158Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.701 in 1,613,958 control chromosomes in the GnomAD database, including 409,244 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign,drug response (★★). Synonymous variant affecting the same amino acid position (i.e. S158S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.61 ( 31114 hom., cov: 32)
Exomes 𝑓: 0.71 ( 378130 hom. )

Consequence

SLC29A3
NM_018344.6 missense

Scores

2
6
8

Clinical Significance

Benign; drug response criteria provided, multiple submitters, no conflicts B:8O:3

Conservation

PhyloP100: 7.50

Publications

57 publications found
Variant links:
Genes affected
SLC29A3 (HGNC:23096): (solute carrier family 29 member 3) This gene encodes a nucleoside transporter. The encoded protein plays a role in cellular uptake of nucleosides, nucleobases, and their related analogs. Mutations in this gene have been associated with H syndrome, which is characterized by cutaneous hyperpigmentation and hypertrichosis, hepatosplenomegaly, heart anomalies, and hypogonadism. A related disorder, PHID (pigmented hypertrichosis with insulin-dependent diabetes mellitus), has also been associated with mutations at this locus. Alternatively spliced transcript variants have been described.[provided by RefSeq, Mar 2010]
SLC29A3 Gene-Disease associations (from GenCC):
  • H syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia
  • dysosteosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.6845643E-6).
BP6
Variant 10-71351651-C-T is Benign according to our data. Variant chr10-71351651-C-T is described in ClinVar as Benign|drug_response. ClinVar VariationId is 130341.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.755 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018344.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC29A3
NM_018344.6
MANE Select
c.473C>Tp.Ser158Phe
missense
Exon 4 of 6NP_060814.4
SLC29A3
NM_001363518.2
c.239C>Tp.Ser80Phe
missense
Exon 4 of 6NP_001350447.1A0A2R8YDR8
SLC29A3
NM_001174098.2
c.473C>Tp.Ser158Phe
missense
Exon 4 of 6NP_001167569.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC29A3
ENST00000373189.6
TSL:1 MANE Select
c.473C>Tp.Ser158Phe
missense
Exon 4 of 6ENSP00000362285.5Q9BZD2-1
SLC29A3
ENST00000479577.2
TSL:2
c.239C>Tp.Ser80Phe
missense
Exon 4 of 6ENSP00000493995.1A0A2R8YDR8
SLC29A3
ENST00000642198.1
n.156C>T
non_coding_transcript_exon
Exon 3 of 6ENSP00000494827.1A0A2R8Y5U2

Frequencies

GnomAD3 genomes
AF:
0.613
AC:
93188
AN:
151976
Hom.:
31124
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.362
Gnomad AMI
AF:
0.923
Gnomad AMR
AF:
0.587
Gnomad ASJ
AF:
0.736
Gnomad EAS
AF:
0.428
Gnomad SAS
AF:
0.523
Gnomad FIN
AF:
0.741
Gnomad MID
AF:
0.697
Gnomad NFE
AF:
0.760
Gnomad OTH
AF:
0.645
GnomAD2 exomes
AF:
0.639
AC:
160758
AN:
251472
AF XY:
0.650
show subpopulations
Gnomad AFR exome
AF:
0.352
Gnomad AMR exome
AF:
0.485
Gnomad ASJ exome
AF:
0.733
Gnomad EAS exome
AF:
0.456
Gnomad FIN exome
AF:
0.741
Gnomad NFE exome
AF:
0.755
Gnomad OTH exome
AF:
0.697
GnomAD4 exome
AF:
0.711
AC:
1038771
AN:
1461864
Hom.:
378130
Cov.:
63
AF XY:
0.708
AC XY:
514870
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.356
AC:
11914
AN:
33480
American (AMR)
AF:
0.492
AC:
21998
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.734
AC:
19174
AN:
26136
East Asian (EAS)
AF:
0.364
AC:
14468
AN:
39700
South Asian (SAS)
AF:
0.539
AC:
46495
AN:
86256
European-Finnish (FIN)
AF:
0.744
AC:
39722
AN:
53418
Middle Eastern (MID)
AF:
0.714
AC:
4117
AN:
5768
European-Non Finnish (NFE)
AF:
0.755
AC:
839266
AN:
1111986
Other (OTH)
AF:
0.689
AC:
41617
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
17279
34558
51838
69117
86396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20036
40072
60108
80144
100180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.613
AC:
93189
AN:
152094
Hom.:
31114
Cov.:
32
AF XY:
0.610
AC XY:
45321
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.362
AC:
15001
AN:
41458
American (AMR)
AF:
0.586
AC:
8955
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.736
AC:
2556
AN:
3472
East Asian (EAS)
AF:
0.428
AC:
2210
AN:
5162
South Asian (SAS)
AF:
0.523
AC:
2515
AN:
4810
European-Finnish (FIN)
AF:
0.741
AC:
7858
AN:
10606
Middle Eastern (MID)
AF:
0.685
AC:
200
AN:
292
European-Non Finnish (NFE)
AF:
0.760
AC:
51693
AN:
67998
Other (OTH)
AF:
0.643
AC:
1359
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1602
3204
4805
6407
8009
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
752
1504
2256
3008
3760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.703
Hom.:
156226
Bravo
AF:
0.588
TwinsUK
AF:
0.746
AC:
2766
ALSPAC
AF:
0.752
AC:
2900
ESP6500AA
AF:
0.367
AC:
1615
ESP6500EA
AF:
0.747
AC:
6426
ExAC
AF:
0.638
AC:
77492
Asia WGS
AF:
0.460
AC:
1602
AN:
3478
EpiCase
AF:
0.756
EpiControl
AF:
0.759

ClinVar

ClinVar submissions
Significance:Benign; drug response
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
3
H syndrome (3)
-
-
1
not provided (2)
-
-
-
Acanthosis nigricans (1)
-
-
-
Gemcitabine response (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.24
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
T
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.0000037
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Pathogenic
3.1
M
PhyloP100
7.5
PrimateAI
Uncertain
0.54
T
PROVEAN
Uncertain
-4.3
D
REVEL
Benign
0.29
Sift
Benign
0.062
T
Polyphen
0.66
P
Vest4
0.31
MPC
0.39
ClinPred
0.064
T
GERP RS
4.6
Varity_R
0.30
gMVP
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs780668; hg19: chr10-73111408; COSMIC: COSV64385485; COSMIC: COSV64385485; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.